ACR Thyroid Imaging Reporting and Data System (TIRADS) Webinar - Part 3: Why Adopt TIRADS?
Introduction
- Speaker: Dr. Jenny Hong, Neuroradiology, University
- Webinar Focus: The evidence behind adopting ACR TIRADS for thyroid nodule evaluation.
- Webinar Series:
- How TIRADS is implemented.
- Commonly asked questions about TIRADS.
- Why adopt TIRADS?
- Speakers:
- Franklin Tesla, Professor of Radiology, University of Alabama, Birmingham
- Dr. Bill Middleton, Professor of Radiology
- Dr. Jenny Hong
Webinar Objectives
- Discuss the adoption of ACR TIRADS and its benefits.
- Present key articles supporting TIRADS use.
- Interpret and understand these articles to advocate for TIRADS adoption.
Reasons for Adopting ACR TIRADS
- Better patient care through improved report quality and performance.
- Standardization and reduced variability in nodule characterization.
- Specificity and accuracy improvements compared to other systems.
Challenges in Adopting TIRADS
- Concerns about time consumption and radiologist training.
- Initial resistance from referrers and sonographers.
Evidence and Articles Discussed
- Improvements in Report Quality
- Structured reporting templates enhance nodule feature documentation and recommendation consistency.
- Study by Radiology Partners showing improved descriptor quality and reduced ambiguous recommendations.
- Interobserver Variability
- Study showing use of TIRADS reduces variability in interpretation among radiologists.
- Performance Improvement
- Studies demonstrate TIRADS lowers biopsy rates of benign nodules while maintaining high malignancy detection.
- Specificity and accuracy are higher compared to other guidelines like the American Thyroid Association (ATA) guidelines.
Comparison with Other Systems
- ACR TIRADS vs. ATA and SRU Guidelines
- Differences in nodule management recommendations and feature categorization.
- TIRADS offers higher specificity and accuracy.
International and Future Directions
- Collaborative international efforts to harmonize thyroid nodule risk stratification systems.
- Establishment of a multicenter thyroid ultrasound registry for ongoing evaluation and benchmarking.
Conclusion
- ACR TIRADS provides robust framework for thyroid nodule evaluation.
- Encouragement for practices to adopt TIRADS due to its beneficial outcomes in patient care.
- Thanks to the speakers and organizers for the informative session.
Resources:
- Visit the ACR TIRADS website for more information and access to prior webinars.
- Engage with the multicenter thyroid ultrasound registry for practice benchmarking.
Final Thoughts: ACR TIRADS improves report quality, reduces variability, and offers superior performance in nodule management decisions. Adoption is encouraged for comprehensive and standardized thyroid nodule evaluation.